Taro Pharmaceutical Industries Ltd (TARO)
42.30
-0.11
(-0.26%)
USD |
NYSE |
May 10, 16:00
42.26
-0.04
(-0.09%)
After-Hours: 20:00
Taro Pharmaceutical Industries Cash from Operations (Quarterly): 30.92M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.92M |
| September 30, 2023 | 47.52M |
| June 30, 2023 | 7.777M |
| March 31, 2023 | 56.65M |
| December 31, 2022 | 12.77M |
| September 30, 2022 | 20.36M |
| June 30, 2022 | -58.03M |
| March 31, 2022 | 41.26M |
| December 31, 2021 | -191.93M |
| September 30, 2021 | -52.02M |
| June 30, 2021 | 43.99M |
| March 31, 2021 | 51.06M |
| December 31, 2020 | 42.86M |
| September 30, 2020 | -112.26M |
| June 30, 2020 | 64.11M |
| March 31, 2020 | 49.60M |
| December 31, 2019 | 98.65M |
| September 30, 2019 | 40.75M |
| June 30, 2019 | 82.60M |
| March 31, 2019 | 58.58M |
| December 31, 2018 | 107.48M |
| September 30, 2018 | 75.21M |
| June 30, 2018 | 82.44M |
| March 31, 2018 | 97.89M |
| December 31, 2017 | 87.10M |
| Date | Value |
|---|---|
| September 30, 2017 | 66.03M |
| June 30, 2017 | 72.67M |
| March 31, 2017 | 117.08M |
| December 31, 2016 | 127.78M |
| September 30, 2016 | 136.71M |
| June 30, 2016 | 55.96M |
| March 31, 2016 | 155.42M |
| December 31, 2015 | 110.39M |
| September 30, 2015 | 61.06M |
| June 30, 2015 | 68.27M |
| March 31, 2015 | 213.95M |
| December 31, 2014 | 96.69M |
| September 30, 2014 | 60.42M |
| June 30, 2014 | 35.73M |
| March 31, 2014 | 83.93M |
| December 31, 2013 | 114.03M |
| September 30, 2013 | 95.27M |
| June 30, 2013 | 64.41M |
| March 31, 2013 | 75.55M |
| December 31, 2012 | 91.61M |
| September 30, 2012 | 62.28M |
| June 30, 2012 | 19.21M |
| December 31, 2011 | 61.52M |
| September 30, 2011 | 62.18M |
| June 30, 2011 | 33.35M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-191.93M
Minimum
Dec 2021
98.65M
Maximum
Dec 2019
14.56M
Average
41.26M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| InspireMD Inc | -4.177M |
| BiomX Inc | -6.242M |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | -3.649M |
| Holdco Nuvo Group DG Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 81.67M |
| Free Cash Flow | 86.00M |
| Free Cash Flow Per Share (Quarterly) | -0.0945 |
| Free Cash Flow to Equity (Quarterly) | -3.553M |
| Free Cash Flow to Firm (Quarterly) | -3.553M |
| Free Cash Flow Yield | 5.41% |